Characterization of the novel HLA‐DRB3*02:194 allele by sequencing‐based typing
HLA · 2024
DOI: 10.1111/tan.15353 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Lucie Blandin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Base Sequence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
HLA‐DRB3*02:194 differs from HLA‐DRB3*02:02:01:02 by one nucleotide substitution in codon 78 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
- Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
- University Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.
- Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.
ORCID-Profile: Jonathan Visentin, Richard Lemal, Paul Rouzaire
Zitieren
APA
Blandin, L., Visentin, J., Guidicelli, G., Lemal, R., & Rouzaire, P. (2024). Characterization of the novel HLA‐DRB3*02:194 allele by sequencing‐based typing. HLA. https://doi.org/10.1111/tan.15353
Vancouver
Blandin L, Visentin J, Guidicelli G, Lemal R, Rouzaire P. Characterization of the novel HLA‐DRB3*02:194 allele by sequencing‐based typing. HLA. 2024. doi:10.1111/tan.15353
BibTeX
@article{Blandin2024,
author = {Blandin, Lucie and Visentin, Jonathan and Guidicelli, Gwendaline and Lemal, Richard and Rouzaire, Paul},
title = {Characterization of the novel HLA‐DRB3*02:194 allele by sequencing‐based typing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15353}
}
EUVIMED